Home / Life Sciences
Category: Life Sciences

With the pandemic leaving many searching, group support app Circles raises new round

Between one-to-one therapy and free online forums, people search for a range of solutions to mental health therapy online. Especially since the...

Read more

Pandas wants to give Latin American businesses buying power in Asia

Pandas connects LatAm businesses directly with Asian suppliers to reduce logistical problems and high fees often imposed by importers and...

Read more

Digital biomarkers are healthcare’s next frontier

Historically, continuous tracking of an individual’s vital signs meant they had to be in a hospital. But that's not true anymore.

Read more

Planetary wants to help food startups brew up more fake meat

Planetary aims to bring all of the alternative protein production planets into orbit with its scaling technology.

Read more

6 questions investors should ask when evaluating psychedelic biotech companies

We believe in a future where psychedelic therapy will be as common as going to the dentist, but the path won’t be easy.

Read more

NovaXS Biotech raises $1.5M to make injection therapy needle-free

A startup spawned from a lab at the University of California, Berkeley has won investor support to work on its patented needle-free injector, which...

Read more

Startup Battlefield winner Cellino grabs $80M Series A

Cellino Bio’s founder Nabiha Saklayen didn’t initially intend to enter TechCrunch Disrupt 2021’s Startup Battlefield — it was her PR...

Read more

Novo, the SMB neobank, nabs $90M at a $700M valuation

Novo, the startup building a new kind of banking service from the ground up for small and medium businesses, has closed a significant round of...

Read more

Nabla Bio raises $11M for an “end-to-end” antibody design platform

Nabla Bio, a Boston, Massachusetts based startup, announced a $11 million seed round on Monday. The company, founded in May 2020, is looking to enter...

Read more

Vinehealth, offering digital support for cancer patients and SaaS for R&D, gets $5.5M to launch in the US

Vinehealth, a 2018-founded, London-based digital health startup that’s built an app offering personalized support for cancer patients while...

Read more

Tiamat Sciences cooking up plant-based proteins for cheaper production of cellular meat

Adil estimates that today’s growth factor costs $2 million per gram to make, but she believes that with efforts from Tiamat Sciences and others,...

Read more

Generate Biomedicines raises $370M Series B with a focus on protein-based drugs

The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a...

Read more

Medable reaches $2.1B valuation as Tiger, Blackstone, GSR pump new capital into clinical trials management company

Medable has grown 300% in the past year and over 800% in the last 18 months, which CEO Michelle Longmire said was proof that a patient-centered...

Read more

Artificial raises $21M led by Microsoft’s M12 for a lab automation platform aimed at life sciences R&D

Automation is extending into every aspect of how organizations get work done, and today comes news of a startup that is building tools for one...

Read more

Biden proposes ARPA-H, a health research agency to ‘end cancer’ modeled after DARPA

In a joint address to Congress last night, President Biden updated the nation on vaccination efforts and outlined his administration’s ambitious...

Read more

ElevateBio raises $525M to advance its cell and gene therapy technologies

ElevateBio, one of the leading biotech companies focused on gene-based therapies, has raised a massive $525 million Series C round of financing, more...

Read more

New clinical trial data from Locus Biosciences shows promise in CRISPR-Cas3 technology

Antibiotic resistance is one of the biggest potential threats to global health today. But Locus Biosciences is hoping that their crPhage technology...

Read more

Immunai raises $60M as it expands from improving immune therapies to discovering new ones, too

Just two years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million....

Read more

BioNTech founder Uğur Şahin and Mayfield’s Ursheet Parikh are coming to Disrupt

It’s hard to argue that any technology company has had a greater impact in the past decade than BioNTech, the mRNA-based therapeutics pioneer...

Read more

“Alzheimer’s is open for business:” Controversial FDA approval could pave the way for future drugs

On Monday, a 17-year drought in the world of Alzheimer’s drugs ended with the FDA approval of Biogen’s Aduhlem (aducanumab). The controversy...

Read more

After contentious debate, FDA approves first Alzheimer’s drug since 2003

On Monday, the US Food and Drug Administration granted approval to a keenly-watched Alzheimer’s drug, aducanumab, developed by the drugmaker...

Read more

Latest 20